K. Tatsugami

发表

Targeting ribosomal S6 kinases/Y‐box binding protein‐1 signaling improves cellular sensitivity to taxane in prostate cancer

T. Uchiumi, M. Shiota, M. Itsumi, 2014, The Prostate.

Sensitivity of doxorubicin-resistant cells to sorafenib: possible role for inhibition of eukaryotic initiation factor-2alpha phosphorylation.

T. Uchiumi, M. Shiota, M. Itsumi, 2010, International journal of oncology.

Mechanism of synergistic antitumor effect of sorafenib and interferon-α on treatment of renal cell carcinoma.

A. Takeuchi, K. Tatsugami, S. Naito, 2010, The Journal of urology.

Posttransplant Administration of Cyclophosphamide and Donor Lymphocyte Infusion Induces Potent Antitumor Immunity to Solid Tumor

M. Tsuneyoshi, A. Takeuchi, K. Tatsugami, 2008, Clinical Cancer Research.

Cyclophosphamide-Using Nonmyeloablative Allogeneic Cell Therapy against Renal Cancer with a Reduced Risk of Graft-versus-Host Disease

M. Tsuneyoshi, K. Tatsugami, S. Naito, 2007, Clinical Cancer Research.

PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells.

T. Uchiumi, M. Shiota, M. Itsumi, 2014, Journal of molecular endocrinology.

Apparent diffusion coefficient characteristics of various adrenal tumors.

H. Honda, Y. Takayama, A. Nishie, 2014, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.

Y. Oda, T. Uchiumi, M. Shiota, 2016, Journal of the National Cancer Institute.

A case report of primary malignant melanoma of male urethra with distinct appearance in multiple regions

Y. Oda, M. Shiota, A. Yokomizo, 2016, International Cancer Conference Journal.

Relationship Among Tumor Attenuation Value of Pre-contrast Computed Tomography (CT), Washout Rate and Constituent Cells in Adrenal Adenoma: Proposition of a New Approach for Diagnosing Adrenal Adenoma on Dynamic CT

H. Honda, Y. Takayama, A. Nishie, 2018, AntiCancer Research.

Pathological manifestation of difference in washout pattern of adrenal hyperplasia on dynamic CT

H. Honda, Y. Takayama, A. Nishie, 2014, Journal of medical imaging and radiation oncology.

Secondary bladder cancer after anticancer therapy for prostate cancer: Reduced comorbidity after androgen-deprivation therapy.

H. Honda, M. Shiota, A. Yokomizo, 2015 .

Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5&agr;‐Reductase Inhibitor

M. Shiota, A. Yokomizo, A. Takeuchi, 2017, The Journal of urology.

Prognostic and Predictive Factors for Anti-androgen Withdrawal in Castration-resistant Prostate Cancer

M. Shiota, A. Takeuchi, E. Kashiwagi, 2018, AntiCancer Research.

Inhibitionof RSK/YB-1Signaling Enhancesthe Anti-Cancer Effectof Enzalutamidein Prostate Cancer

T. Uchiumi, M. Shiota, M. Itsumi, 2014 .

Inhibition of RSK/YB‐1 signaling enhances the anti‐cancer effect of enzalutamide in prostate cancer

T. Uchiumi, M. Shiota, M. Itsumi, 2014, The Prostate.

Cancer Therapy : Preclinical Inhibition of Protein Kinase C / Twist 1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer

T. Uchiumi, M. Shiota, A. Yokomizo, 2014 .

Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer

T. Uchiumi, M. Shiota, A. Yokomizo, 2013, Clinical Cancer Research.

Immunotherapy for Renal Cell Carcinoma

M. Itsumi, K. Tatsugami, 2010, Clinical & developmental immunology.

Dendritic cell therapy in combination with interferon‐α for the treatment of metastatic renal cell carcinoma

K. Akashi, T. Miyamoto, K. Tatsugami, 2008, International journal of urology : official journal of the Japanese Urological Association.

Clinical significance of programmed death‐1 and programmed death‐ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma

M. Oya, K. Tatsugami, N. Shinohara, 2019, Cancer science.

The efficacy of laparoscopic radical nephrectomy for renal cell cancer in the elderly: An oncological outcome analysis

A. Yokomizo, K. Tatsugami, S. Naito, 2008, International journal of urology : official journal of the Japanese Urological Association.

Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment

H. Akaza, M. Oya, K. Tatsugami, 2018, Oncotarget.

Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients

M. Oya, Y. Tomita, K. Tatsugami, 2020, International journal of urology : official journal of the Japanese Urological Association.

Final results of a phase II study of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma.

H. Akaza, Y. Tomita, M. Fujisawa, 2014, Japanese journal of clinical oncology.

Renal cancer treatment with low levels of mixed chimerism induced by nonmyeloablative regimen using cyclophosphamide in mice.

M. Tsuneyoshi, K. Tatsugami, S. Naito, 2005, Cancer research.

Donor CD4 T cells are critical in allogeneic stem cell transplantation against murine solid tumor.

A. Takeuchi, K. Tatsugami, S. Naito, 2009, Cancer research.

Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction

K. Matsuda, T. Mushiroda, M. Kubo, 2016, PloS one.

P300/CBP‐associated factor regulates Y‐box binding protein‐1 expression and promotes cancer cell growth, cancer invasion and drug resistance

Ken Yamamoto, K. Kuroiwa, T. Uchiumi, 2010, Cancer science.

Evidence of the extrathymic development of tyrosinase‐related protein‐2‐recognizing CD8+ T cells with low avidity

K. Tatsugami, Hisakata Yamada, K. Nomoto, 2001, Immunology.

Equol inhibits prostate cancer growth through degradation of androgen receptor by S‐phase kinase‐associated protein 2

T. Uchiumi, M. Shiota, M. Itsumi, 2016, Cancer science.

A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases.

M. Shiota, A. Yokomizo, A. Takeuchi, 2018, Molecular and clinical oncology.

Relationship between body composition and hormone sensitivity for androgen deprivation therapy in patients with metastatic prostate cancer

M. Shiota, A. Takeuchi, K. Imada, 2019, Prostate international.

Editorial Comment to Prediction models for progression of non‐muscle‐invasive bladder cancer: A review

K. Tatsugami, 2018, International journal of urology : official journal of the Japanese Urological Association.

Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancer.

K. Kuroiwa, Y. Oda, T. Uchiumi, 2012, The Journal of urology.

Thickness of Perirenal Fat Predicts the Growth Pattern of Renal Cell Carcinoma

M. Shiota, A. Takeuchi, K. Imada, 2020 .

Thick perirenal fat predicts the growth pattern of renal cell carcinoma.

M. Shiota, A. Takeuchi, K. Imada, 2019, Journal of Clinical Oncology.

Thick perirenal fat predicts the growth pattern of renal cell carcinoma

M. Shiota, A. Takeuchi, K. Imada, 2019, bioRxiv.

Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men.

T. Uchiumi, M. Shiota, A. Takeuchi, 2019, Clinical genitourinary cancer.

The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men

T. Uchiumi, M. Shiota, A. Takeuchi, 2019, Cancer Chemotherapy and Pharmacology.

Prognostic significance of antihypertensive agents in men with castration-resistant prostate cancer.

M. Shiota, A. Takeuchi, E. Kashiwagi, 2019, Urologic oncology.

Serum testosterone level as possible predictive marker in androgen receptor axis-targeting agents and taxane chemotherapies for castration-resistant prostate cancer.

M. Shiota, A. Takeuchi, K. Imada, 2019, Urologic oncology.

Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy

M. Shiota, A. Takeuchi, K. Imada, 2019, The Prostate.

Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer

M. Shiota, A. Takeuchi, E. Kashiwagi, 2019, Prostate international.

Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With De Novo Metastatic Prostate Cancer

M. Shiota, A. Takeuchi, K. Imada, 2019, AntiCancer Research.

The Association of Polymorphisms in the Gene Encoding Gonadotropin‐Releasing Hormone with Serum Testosterone Level during Androgen Deprivation Therapy and Prognosis of Metastatic Prostate Cancer

T. Uchiumi, M. Shiota, A. Yokomizo, 2017, The Journal of urology.

Serum testosterone before and during androgen‐deprivation therapy, and prognosis between cigarette smokers and nonsmokers with metastatic prostate cancer

M. Shiota, A. Takeuchi, K. Imada, 2018, Andrologia.

Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.

Y. Oda, T. Uchiumi, M. Shiota, 2015, Endocrine-related cancer.

The oncological outcomes and risk stratification in docetaxel chemotherapy for castration-resistant prostate cancer.

M. Shiota, A. Yokomizo, A. Takeuchi, 2014, Japanese journal of clinical oncology.

Development of Robotic Urologic Surgery in Asia

A. Chiu, H. Garg, H. Sim, 2019, Endourology Progress.

Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer

M. Shiota, A. Takeuchi, K. Imada, 2019, Andrologia.

Circulating immunoglobulin‐bound transforming growth factor β at a late tumour‐bearing stage impairs antigen‐specific responses of CD4+ T cells

K. Tatsugami, K. Nomoto, M. Harada, 2002, Clinical and experimental immunology.

Gene polymorphisms in antioxidant enzymes correlate with the efficacy of androgen-deprivation therapy for prostate cancer with implications of oxidative stress

T. Uchiumi, M. Shiota, M. Itsumi, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells

K. Kuroiwa, M. Shiota, A. Yokomizo, 2011, The Prostate.

A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti‐tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice

A. Takeuchi, K. Tatsugami, S. Naito, 2012, International journal of cancer.

Influence of immunotherapy with interferon-alpha on regulatory T cells in renal cell carcinoma patients.

K. Tatsugami, S. Naito, M. Eto, 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Characterization of B16 melanoma-specific cytotoxic T lymphocytes

K. Tamada, K. Tatsugami, G. Kimura, 1998, Cancer Immunology, Immunotherapy.

Causes of diminished renal function in the affected kidney after partial nephrectomy

K. Kuroiwa, A. Yokomizo, J. Inokuchi, 2012, BJU international.

Impact of cold and warm ischemia on postoperative recovery of affected renal function after partial nephrectomy.

K. Kuroiwa, A. Yokomizo, A. Takeuchi, 2011, Journal of endourology.

Tumor-infiltrating lymphocyte-mediated pleuritis followed by marked shrinkage of metastatic kidney cancer of the chest wall during nivolumab treatment.

Y. Nakanishi, A. Takeuchi, E. Kashiwagi, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.

K. Kuroiwa, Y. Oda, T. Uchiumi, 2011, Endocrine-related cancer.

Renal cancer treatment with recipient lymphocyte infusion enhanced the antitumor effect of nonmyeloablative allogeneic stem cell transplantation.

M. Shiota, M. Itsumi, A. Yokomizo, 2015, Transplant immunology.

Clinical Outcomes in Patients With Metastatic Papillary Renal‐Cell Carcinoma: A Multi‐Institutional Study in Japan

M. Oya, Y. Tomita, K. Tatsugami, 2018, Clinical genitourinary cancer.

Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era

T. Yamasaki, K. Tatsugami, S. Naito, 2015, International journal of urology : official journal of the Japanese Urological Association.

Allogeneic cell therapy from immunized donors with tumor antigen peptide enhances the antitumor effect after cyclophosphamide‐using non‐myeloablative allogeneic hematopoietic cell transplantation

A. Takeuchi, K. Tatsugami, S. Naito, 2009, Cancer science.

Local injections of OK432 can help the infiltration of adoptively transferred CD8+ T cells into the tumor sites and synergistically induce the local production of Th1-type cytokines and CXC3 chemokines

K. Tamada, K. Tatsugami, K. Nomoto, 2000, Cancer Immunology, Immunotherapy.

Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppression

K. Kuroiwa, M. Shiota, A. Yokomizo, 2011, Cancer Chemotherapy and Pharmacology.

Anti‐tumour activity of heat‐shock protein 60‐recognizing CD4+ T cells against syngeneic murine renal cell carcinoma

K. Tatsugami, S. Naito, G. Matsuzaki, 2005, BJU international.

Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study.

M. Oya, Y. Tomita, K. Tatsugami, 2020, Japanese journal of clinical oncology.

Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade

Y. Oda, N. Hamada, Y. Nakanishi, 2018, Oncotarget.

Dendritic-cell therapy after non-myeloablative stem-cell transplantation for renal-cell carcinoma.

M. Harada, K. Tatsugami, S. Naito, 2004, The Lancet. Oncology.

In vitro and in vivo analysis of synergistic antitumor effects of interferon-α and sorafenib in renal cell carcinoma

A. Takeuchi, K. Tatsugami, S. Naito, 2008 .

Holmium laser enucleation of the prostate: comparison of outcomes according to prostate size in 97 Japanese patients.

K. Tatsugami, S. Naito, N. Seki, 2007, Journal of endourology.

Nephrolithiasis as an extra-intestinal presentation of pediatric inflammatory bowel disease unclassified.

H. Takada, T. Hara, K. Tatsugami, 2010, Journal of Crohn's & Colitis.

Successful management of cryptococcosis of the bilateral adrenal glands and liver by unilateral adrenalectomy with antifungal agents: a case report

K. Ohnaka, J. Inokuchi, K. Tatsugami, 2011, BMC infectious diseases.

The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang).

K. Tamada, K. Tatsugami, K. Nomoto, 1999, Immunopharmacology.

Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus

M. Yasuda, M. Fujisawa, S. Egawa, 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y-Box–Binding Protein 1, and E-Cadherin Regulation

K. Kuroiwa, Y. Oda, T. Uchiumi, 2010, Clinical Cancer Research.

Sorafenib with doxorubicin augments cytotoxicity to renal cell cancer through PERK inhibition.

K. Kuroiwa, T. Uchiumi, M. Shiota, 2010, International journal of oncology.

p300 mediates cellular resistance to doxorubicin in bladder cancer.

K. Kuroiwa, M. Shiota, A. Yokomizo, 2011, Molecular medicine reports.

Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines

A. Yokomizo, J. Inokuchi, K. Tatsugami, 2005, Oncogene.

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

K. Kuroiwa, T. Uchiumi, M. Shiota, 2010, Cancer science.

Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer

T. Uchiumi, M. Shiota, A. Takeuchi, 2020, Cancer Immunology, Immunotherapy.

Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.

K. Kuroiwa, T. Uchiumi, M. Shiota, 2010, Molecular endocrinology.

Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylation.

K. Kuroiwa, M. Shiota, M. Itsumi, 2012, International journal of oncology.

Nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan

M. Yasuda, M. Fujisawa, S. Egawa, 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Exploring immune therapy for renal cancer.

Y. Tomita, K. Tatsugami, S. Naito, 2011, International journal of urology : official journal of the Japanese Urological Association.

Predictive factors of biochemical recurrence after radical prostatectomy for high‐risk prostate cancer

K. Tatsugami, M. Hamaguchi, M. Yoshikawa, 2018, International journal of urology : official journal of the Japanese Urological Association.

Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity

T. Irie, A. Takeuchi, E. Kashiwagi, 2019, Clinical Cancer Research.

Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide

T. Uchiumi, M. Shiota, A. Takeuchi, 2018, The Prostate.

MP24-06 INTERACTION BETWEEN DOCETAXEL RESISTANCE AND CASTRATION RESISTANCE IN PROSTATE CANCER: IMPLICATIONS OF TWIST1, YB-1 AND ANDROGEN RECEPTOR

T. Uchiumi, M. Shiota, M. Itsumi, 2014 .

Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of twist1, YB‐1, and androgen receptor

T. Uchiumi, M. Shiota, A. Yokomizo, 2013, The Prostate.

In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor.

H. Ueno, K. Tatsugami, S. Naito, 2006, Oncology reports.

Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy

H. Honda, M. Shiota, A. Yokomizo, 2015, Oncotarget.

Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants

T. Uchiumi, M. Shiota, A. Takeuchi, 2018, Cancer science.

Independent validation of missense polymorphism in HSD3B1 in Japanese men treated with primary androgen-deprivation therapy for metastatic prostate cancer.

T. Uchiumi, M. Shiota, A. Takeuchi, 2018 .

Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer.

M. Shiota, A. Yokomizo, A. Takeuchi, 2016, International immunopharmacology.

Impact of Surgeon and Hospital Volume on the Safety of Robot-Assisted Radical Prostatectomy: A Multi-Institutional Study Based on a National Database

K. Tozawa, M. Fujisawa, K. Tatsugami, 2017, Urologia Internationalis.

Laparoscopic adrenalectomy for malignant tumors

A. Yokomizo, K. Tatsugami, S. Naito, 2008, International journal of urology : official journal of the Japanese Urological Association.

YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α

K. Kuroiwa, M. Shiota, M. Itsumi, 2013, Cancer Immunology, Immunotherapy.

Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy

T. Uchiumi, M. Shiota, A. Takeuchi, 2018, Front. Oncol..

Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer.

T. Uchiumi, M. Shiota, A. Yokomizo, 2017, Endocrine-related cancer.

Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer

M. Shiota, A. Yokomizo, A. Takeuchi, 2014, Supportive Care in Cancer.

Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy

K. Tatsugami, S. Naito, N. Shinohara, 2015, Cancer science.

Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan

K. Harada, Yoshio Anazawa, Y. Tomita, 2018, International journal of urology : official journal of the Japanese Urological Association.

The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy

M. Shiota, A. Yokomizo, A. Takeuchi, 2014, Journal of surgical oncology.

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone

M. Shiota, A. Takeuchi, K. Imada, 2017, Prostate international.

What affects the results of a laparoscopic adrenalectomy for pheochromocytoma? Evaluation with respect to intraoperative blood pressure and state of tumor.

A. Yokomizo, K. Tatsugami, S. Naito, 2009, Journal of endourology.

Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan

T. Fujioka, K. Tatsugami, S. Naito, 2015, BMC Cancer.

Long-term outcome of hand-assisted laparoscopic radical nephrectomy for localized stage T1/T2 renal-cell carcinoma.

K. Tatsugami, S. Naito, H. Nomura, 2005, Journal of endourology.

Human heterochromatin protein 1 isoforms regulate androgen receptor signaling in prostate cancer.

T. Uchiumi, M. Shiota, M. Itsumi, 2013, Journal of molecular endocrinology.

The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapy

M. Shiota, A. Yokomizo, A. Takeuchi, 2015, Journal of Cancer Research and Clinical Oncology.

Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma

M. Oya, K. Tatsugami, Yoshihiko Tomita, 2023, International Journal of Clinical Oncology.

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial

R. Motzer, M. Oya, I. Davis, 2018, Journal of Hematology & Oncology.

Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer.

H. Nishiyama, K. Kuroiwa, S. Fukushima, 2010, Journal of endourology.

Comparison of standard and hand-assisted laparoscopic radical nephrectomy for renal cell carcinoma.

A. Yokomizo, K. Tatsugami, S. Naito, 2007, Fukuoka igaku zasshi = Hukuoka acta medica.

Surgical and oncologic outcomes of laparoscopic partial nephrectomy: a Japanese multi-institutional study of 1375 patients.

T. Matsuda, K. Nakagawa, A. Kawauchi, 2012, Journal of endourology.

Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.

K. Kuroiwa, M. Yasuda, M. Fujisawa, 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism

M. Shiota, A. Yokomizo, A. Takeuchi, 2016, Prostate Cancer and Prostatic Diseases.

Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer

M. Shiota, A. Yokomizo, K. Imada, 2019, AntiCancer Research.

Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer.

H. Honda, M. Shiota, A. Yokomizo, 2016, Japanese journal of clinical oncology.

Methyltransferase inhibitor adenosine dialdehyde suppresses androgen receptor expression and prostate cancer growth.

M. Shiota, A. Yokomizo, A. Takeuchi, 2012, The Journal of urology.

Reality of nerve sparing and surgical margins in surgeons’ early experience with robot‐assisted radical prostatectomy in Japan

K. Tozawa, M. Fujisawa, K. Tatsugami, 2017, International journal of urology : official journal of the Japanese Urological Association.

Co‐introduction of a steroid with docetaxel chemotherapy for metastatic castration‐resistant prostate cancer affects PSA flare

M. Shiota, A. Yokomizo, A. Takeuchi, 2016, BJU international.

The Differential Impact of Body Mass Index and the Feature of Metabolic Syndrome on Oncological Outcomes Following Different Surgical Procedures in Japanese Men with Prostate Cancer

M. Shiota, A. Yokomizo, A. Takeuchi, 2017, Annals of surgical oncology.

Surgical Navigation Improves Renal Parenchyma Volume Preservation in Robot-Assisted Partial Nephrectomy: A Propensity Score-matched Comparative Analysis.

M. Hashizume, J. Inokuchi, K. Tatsugami, 2019, The Journal of urology.

Assessment of surgical skills by using surgical navigation in robot-assisted partial nephrectomy

Makoto Hashizume, Pierre Jannin, Byunghyun Cho, 2019, International Journal of Computer Assisted Radiology and Surgery.

SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy.

T. Uchiumi, M. Shiota, M. Itsumi, 2015, European journal of cancer.

Smoking effect on oncological outcome among men with prostate cancer after radical prostatectomy

M. Shiota, A. Yokomizo, A. Takeuchi, 2017, Japanese journal of clinical oncology.

A safe combined nephrectomy and right lobectomy using the liver hanging maneuver for huge renal cell carcinoma directly invading the right lobe of the liver: report of a case

Y. Maehara, K. Shirabe, N. Harada, 2013, Surgery Today.

Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer.

K. Kuroiwa, M. Shiota, A. Yokomizo, 2012, The Journal of urology.

A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data

H. Miyake, N. Hinata, K. Tatsugami, 2020, International Journal of Clinical Oncology.

Transurethral endoscopic treatment of patients with upper tract urothelial carcinomas using neodymium‐YAG and/or holmium‐YAG laser ablation

K. Kuroiwa, A. Yokomizo, K. Tatsugami, 2010, BJU international.

Clinical factors affecting perioperative outcomes in robot-assisted radical prostatectomy.

M. Shiota, A. Takeuchi, E. Kashiwagi, 2018, Molecular and clinical oncology.

The change of the split renal function before and after a nephrectomy using Tc-mercaptoacetyltriglycine (MAG3).

K. Tatsugami, S. Naito, Motonobu Nakamura, 2005, Fukuoka igaku zasshi = Hukuoka acta medica.

Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate

M. Shiota, A. Yokomizo, J. Inokuchi, 2014, World Journal of Urology.

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer

M. Shiota, J. Inokuchi, K. Tatsugami, 2018, International journal of urology : official journal of the Japanese Urological Association.

Prognostic Significance of Preoperative Urine Cytology in Low-grade Non-muscle-invasive Bladder Cancer.

M. Shiota, A. Yokomizo, A. Takeuchi, 2016, Anticancer research.

Real-world use of sorafenib for advanced renal cell carcinoma patients with cardiovascular disease: nationwide survey in Japan

H. Akaza, M. Oya, K. Tatsugami, 2020, Expert review of anticancer therapy.

Little Impact on Renal Function in Advanced Renal Cell Carcinoma Patients Treated with Sorafenib--Analyses of Postmarketing Surveillance in Japan in over 3,200 Consecutive Cases.

H. Akaza, M. Oya, K. Tatsugami, 2016, Gan to kagaku ryoho. Cancer & chemotherapy.

Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis

H. Akaza, M. Oya, K. Tatsugami, 2018, British Journal of Cancer.

Prognostic Impact of Serum Testosterone and Body Mass Index Before Androgen-deprivation Therapy in Metastatic Prostate Cancer.

M. Shiota, A. Yokomizo, A. Takeuchi, 2015, Anticancer research.

Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml.

M. Shiota, A. Yokomizo, A. Takeuchi, 2015, Anticancer research.

Progression to bone-marrow carcinomatosis and extraosseous legion during treatment with radium-223 for multiple bone metastases

S. Baba, H. Honda, Y. Oda, 2018, International Cancer Conference Journal.

Real-world treatment outcomes of patients with penile cancer in the Kyushu-Okinawa area of Japan in the pre-guideline era.

K. Tatsugami, T. Kamoto, S. Tatarano, 2023, Japanese journal of clinical oncology.

Acute urinary morbidity after a permanent 125I implantation for localized prostate cancer

H. Honda, Y. Shioyama, K. Tatsugami, 2014, Journal of radiation research.

A pooled analysis of the efficacy and safety of cabozantinib post immunotherapy in patients with advanced renal cell carcinoma.

R. Motzer, T. Choueiri, M. Oya, 2020 .

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma

T. Tsuzuki, T. Yamasaki, M. Oya, 2021, International Journal of Clinical Oncology.

Editorial Comment to Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives

K. Tatsugami, 2019, International journal of urology.

A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma

T. Deguchi, K. Tatsugami, S. Naito, 2012, Cancer science.